Franklin Cudjoe reports positive recovery after brain surgery, DBS implant to be activated in two weeks
Founding President of IMANI Africa, Franklin Cudjoe, has announced encouraging progress in his recovery following brain surgery in the United States, revealing that his doctors are expected to…
Journalist
Published 6 min read

Founding President of IMANI Africa, Franklin Cudjoe, has announced encouraging progress in his recovery following brain surgery in the United States, revealing that his doctors are expected to activate his implanted Deep Brain Stimulation (DBS) device in approximately two weeks.
In an update shared on Tuesday, November 17, Mr Cudjoe said his physician, Dr Okeanis Vaou, had informed him that his brain was healing well following the procedure performed at Rush University Medical Center in Chicago.
He disclosed the latest development after having lunch with Dr Vaou and Ahmeena, who has been accompanying him during his medical journey in the United States.
According to Mr Cudjoe, the next major stage of his treatment will involve switching on the implanted device, a development he described optimistically as the moment when the “magic” would happen.
“Dr Vaou brought news that my brain was healing well and in two weeks she plans to turn on the implant. Then, the ‘magic’ will happen,” he said.
He expressed confidence in his medical team, noting that Dr Vaou had successfully navigated more than 100 Deep Brain Stimulation implant procedures.
“She has successfully navigated over 100 Deep Brain Stimulation implants and I look forward to being the next!” he added.
Mr Cudjoe also appealed to Ghanaians, friends and supporters to continue remembering him in their thoughts and prayers as he prepares for the next phase of treatment.
From surgery to the activation stage
The latest update marks another important milestone in Mr Cudjoe’s medical journey, which has attracted considerable public attention since he disclosed his preparations for specialised treatment in the United States.
He underwent surgery at Rush University Medical Center in Chicago in early November and was subsequently discharged from hospital to continue his recovery at an apartment.
Following his discharge on November 6, he announced that he would spend approximately two weeks healing before proceeding to the next stage of treatment.
The latest assessment from Dr Vaou suggests that his recovery is progressing positively and that the medical team is preparing to activate the implanted stimulation system.
Dr Vaou is a movement disorders neurologist and sleep medicine specialist at Rush University Medical Center, with expertise in Parkinson’s disease, Deep Brain Stimulation and advanced neuromodulation therapies.
According to her professional profile, she has nearly two decades of experience in Deep Brain Stimulation and has developed and led specialised DBS and focused ultrasound programmes.
Her work includes complex DBS programming, brain sensing and adaptive stimulation technologies.
Understanding the Deep Brain Stimulation procedure
Deep Brain Stimulation is an advanced surgical treatment used to manage symptoms associated with neurological conditions, particularly Parkinson’s disease, essential tremor and dystonia.
The procedure involves implanting thin electrodes into carefully selected areas of the brain. These electrodes are connected to a small, battery-powered device, usually positioned beneath the skin near the chest.
The device sends controlled electrical impulses to targeted brain regions, helping regulate abnormal electrical activity associated with movement difficulties.
For people living with Parkinson’s disease, DBS can help manage symptoms such as tremors, muscle stiffness, slowed movement and involuntary movements.
One of the important features of the technology is that its stimulation settings can be adjusted by specialists to suit individual patients.
However, activation is not an instant cure. After the device is switched on, neurologists must carefully programme and fine-tune its settings over several appointments to identify the most effective stimulation levels while minimising possible side effects.
At Rush, initial programming is generally undertaken several weeks after surgery to allow sufficient time for recovery.
Although many patients experience meaningful improvements in movement and quality of life, DBS does not cure Parkinson’s disease or stop its progression. Patients may also continue taking medication, although some may require reduced or adjusted doses.
The upcoming activation will therefore mark the beginning of an important phase of treatment and optimisation for Mr Cudjoe.
Eight years of living with Parkinson’s disease
Mr Cudjoe publicly disclosed in January 2026 that he had been living with Parkinson’s disease for approximately eight years.
He explained that his condition had been managed with the assistance of neurologists in Ghana and through medical treatment abroad.
At the time, he spoke about the challenges of managing the condition, particularly the financial demands of specialised medication, medical consultations and lifestyle adjustments.
He also used his disclosure to encourage greater awareness of neurological disorders and support for people living with Parkinson’s disease.
Parkinson’s is a progressive neurological disorder associated with the loss of dopamine-producing cells in parts of the brain responsible for controlling movement.
Common symptoms include tremors, muscle rigidity, impaired balance and slowness of movement. Some patients also experience sleep disturbances, fatigue and other non-motor symptoms.
Although there is currently no cure, available treatments, including medication, rehabilitation and advanced interventions such as DBS, can help manage symptoms and improve quality of life.
His treatment journey highlights gaps in Ghana’s neurological healthcare
Beyond his personal recovery, Mr Cudjoe has repeatedly drawn attention to the challenges facing patients who require specialised neurological treatment in Ghana.
Before travelling to the United States, he expressed concern about the limited availability of neurologists and specialists with expertise in advanced treatments such as Deep Brain Stimulation.
He previously estimated that Ghana had about 12 general neurologists and raised concerns about the absence of locally available specialists dedicated to DBS treatment.
His medical journey has consequently become an opportunity to highlight the need for investment in neurological healthcare, specialist training, medical equipment and access to essential medicines.
Before his operation, he also disclosed that the estimated cost of the surgical procedure was approximately US$210,000, with additional expenses of about US$150,000 for travel, accommodation and aftercare.
He acknowledged the support of businessman Ibrahim Mahama and other individuals who helped facilitate his medical journey to the United States.
Mr Cudjoe had earlier indicated that IMANI Africa intended to host neurosurgeons and neurologists in Ghana after his recovery to explore opportunities for strengthening the country’s capacity to diagnose and treat neurological conditions.
The proposed engagement is expected to focus on specialist knowledge, equipment, medicines and improved access to advanced neurological care.
Looking ahead with optimism
The latest update has provided renewed encouragement to Mr Cudjoe’s supporters, colleagues and members of the public who have followed his recovery.
His planned DBS activation in approximately two weeks represents another significant step in a medical journey that has involved specialised assessments, surgery and postoperative recovery.
While the effectiveness of the stimulation will become clearer through subsequent programming and medical evaluations, Mr Cudjoe remains optimistic about the prospects of the treatment.
His message was accompanied by a simple appeal to those who have supported him throughout the process: to keep him in their thoughts and prayers as he approaches the next stage of recovery.
For the outspoken policy advocate, the immediate priority is recovery, with hopes that the treatment will improve his quality of life and enable him to return to his usual activities.
Get the AfroAsia Media newsletter
The day's top stories from Africa and Asia, straight to your inbox.
Comments
0 comments
Loading…